Key result
An integrated predictive model fusing image and radiomic features from the entire left ventricular myocardium accurately identified myocardial fibrosis in hypertrophic cardiomyopathy with an AUC of 0.898 and 92.54% sensitivity.
Why the study?
HCM often requires repeated enhanced CMR imaging to detect fibrosis, warranting a non-contrast cine imaging model to identify high-risk patients and avoid unnecessary contrast injection.
Does a radiomic model based on non-contrast cine CMR accurately identify myocardial fibrosis in patients with hypertrophic cardiomyopathy?
Observational (n=273)
No
Does a radiomic model based on non-contrast cine CMR accurately identify myocardial fibrosis in patients with hypertrophic cardiomyopathy?
Effect estimate: AUC 0.898 (95% CI 0.811-0.954)
Absolute Event Rate: 89.02% vs 70.73%
A radiomic model fusing standard CMR and texture features from non-contrast cine imaging can accurately identify myocardial fibrosis in hypertrophic cardiomyopathy, potentially reducing the need for gadolinium contrast administration.
May support non-invasive fibrosis detection in HCM; leaves open prospective validation before clinical adoption.
Objectives Hypertrophic cardiomyopathy (HCM) often requires repeated enhanced cardiac magnetic resonance (CMR) imaging to detect fibrosis. We aimed to develop a practical model based on cine imaging to help identify patients with high risk of fibrosis and screen out patients without fibrosis to avoid unnecessary injection of contrast. Methods A total of 273 patients with HCM were divided into training and test sets at a ratio of 7:3. Logistic regression analysis was used to find predictive image features to construct CMR model. Radiomic features were derived from the maximal wall thickness (MWT) slice and entire left ventricular (LV) myocardium. Extreme gradient boosting was used to build radiomic models. Integrated models were established by fusing image features and radiomic models. The model performance was validated in the test set and assessed by ROC and calibration curve and decision curve analysis (DCA). Results We established five prediction models, including CMR, R1 (based on the MWT slice), R2 (based on the entire LV myocardium), and two integrated models (I CMR+R1 and I CMR+R2 ). In the test set, I CMR+R2 model had an excellent AUC value (0.898), diagnostic accuracy (89.02%), sensitivity (92.54%), and F1 score (93.23%) in identifying patients with positive late gadolinium enhancement. The calibration plots and DCA indicated that I CMR+R2 model was well-calibrated and presented a better net benefit than other models. Conclusions A predictive model that fused image and radiomic features from the entire LV myocardium had good diagnostic performance, robustness, and clinical utility. Key Points • Hypertrophic cardiomyopathy is prone to fibrosis, requiring patients to undergo repeated enhanced cardiac magnetic resonance imaging to detect fibrosis over their lifetime follow-up. • A predictive model based on the entire left ventricular myocardium outperformed a model based on a slice of the maximal wall thickness. • A predictive model that fused image and radiomic features from the entire left ventricular myocardium had excellent diagnostic performance, robustness, and clinical utility.
No takes yet. Share an insight, caveat, or question.
Pu et al. (2022) conducted an observational in Hypertrophic cardiomyopathy (n=273). Integrated radiomic and clinical model (ICMR+R2) vs. Clinical CMR model was evaluated on Identification of positive late gadolinium enhancement (LGE) (AUC 0.898, 95% CI 0.811-0.954). An integrated predictive model fusing image and radiomic features from the entire left ventricular myocardium accurately identified myocardial fibrosis in hypertrophic cardiomyopathy with an AUC of 0.898 and 92.54% sensitivity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: